Corrigendum to: The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemia (Expert Opinion on Drug Safety, (2018), 17, 5, (525-535), 10.1080/14740338.2018.1462335)

摘要

When the above article was first published online, the Drug Summary Box section and Funding section contained an error. These have now been corrected in both the print and online versions, and have also been provided below. Chemical structure (Figure presented.) m = number of 2-fluoro-2-propenoate groupsm = 0.91 n, p = number of crosslinking groupsn + p = 0.09 ●H 2 O = associated water * = indicates an extended polymeric network Image reproduced with permission from Relypsa, Inc., a Vifor Pharma Group Company. ? 2018 Informa UK Limited, trading as Taylor & Francis Group.